Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 3 of 3 citing Goldstein: CDKN2A mutations and melanoma risk in the Icelandic population. (0.05 sec) 

Malignant melanoma in the 21st century: the emerging molecular landscape

- mayoclinicproceedings.com
A Sekulic, P Haluska, AJ Miller, JG De Lamo … - Mayo Clinic Proceedings, 2008 - mayoclinicproceedings.com
Malignant melanoma presents a substantial clinical challenge. Current diagnostic
methods are limited in their ability to diagnose early disease and accurately
predict individual risk of disease progression and outcome. The lack of ...
Cited by 5 - Related articles - All 9 versions

Familial melanoma


J Hansson - Surgical Clinics of North America, 2008 - Elsevier
Cutaneous malignant melanoma (CMM) shows a rapidly rising incidence in
white-skinned populations across the world. It has been estimated that in 2007,
approximately 60,000 new cases of invasive CMM were diagnosed in the United ...
Cited by 1 - Related articles - All 23 versions

Functional impairment of p16INK4A due to CDKN2A p. Gly23Asp missense mutation


MC Scaini, E Rossi, PLA de Siqueira Torres, D … - … Research-Fundamental and Molecular Mechanisms of …, 2009 - Elsevier
The CDKN2A locus encodes for two distinct tumor suppressor proteins, p16 INK4A
and p14 ARF , involved in cell cycle regulation. CDKN2A germline mutations have
been associated with familial predisposition to melanoma and other tumor ...
Related articles - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google